Literature DB >> 33505740

COVID-19 Coinfection with Mycobacterium abscessus in a Patient with Multiple Myeloma.

Jose A Rodriguez1, Charles Bonnano1, Pratik Khatiwada1, Alejandra A Roa1, Daniel Mayer2, Paula A Eckardt3.   

Abstract

BACKGROUND: Coronavirus disease (COVID-19) is a worldwide pandemic causing multiple fatalities and morbidities worldwide. We report a case of severe pneumonia causing acute respiratory distress syndrome due to a coinfection with SARS-CoV-2 and Mycobacterium abscessus in an elderly patient with multiple myeloma in Florida, USA. Case Presentation. An 84-year-old male with a medical history significant for multiple myeloma not in remission was sent to the emergency department to rule out COVID-19 infection prior to continuing his chemotherapy sessions. At presentation, he had nonspecific mild symptoms and an unremarkable physical examination. He had significant blood test findings including serum lactate dehydrogenase 373 U/L, high sensitive C-reactive protein 17.40 mg/l, and ferritin 415 ng/ml. Xpert-SARS-CoV-2 was positive. Chest radiograph revealed patchy areas of interstitial infiltrates in mid to lower lung zones. During his hospitalization course, his oxygenation deteriorated, requiring mechanical intubation. Repeat chest radiograph showed worsening bilateral infiltrates. He was started on broad-spectrum antibiotics and eventually weaned off mechanical intubation and extubated. On the 11th day of admission, he was found to be bradycardic and in shock, and he was reintubated. His labs showed worsening inflammatory markers along with kidney dysfunction to the point of requiring renal replacement therapy. He received both convalescent plasma and remdesivir for treatment of COVID-19 pneumonia. Eventually, repeat blood cultures came back positive for the growth of acid-fast beaded bacilli. While awaiting final culture and sensitivity reports, his antibiotics were upgraded to cover possible nocardia infection. Repeat blood and sputum cultures resulted in growth of AFB bacilli Mycobacterium abscessus 1 week after.
CONCLUSIONS: This case report highlights the importance of keeping a broad differential and considering multiple coinfections, including atypical ones during this COVID-19 pandemic, such as the one that was discussed above, Mycobacterium abscessus, in order to provide goal-directed therapy.
Copyright © 2021 Jose A. Rodriguez et al.

Entities:  

Year:  2021        PMID: 33505740      PMCID: PMC7814410          DOI: 10.1155/2021/8840536

Source DB:  PubMed          Journal:  Case Rep Infect Dis


  12 in total

Review 1.  Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.

Authors:  Timothy M Rawson; Luke S P Moore; Nina Zhu; Nishanthy Ranganathan; Keira Skolimowska; Mark Gilchrist; Giovanni Satta; Graham Cooke; Alison Holmes
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

2.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.

Authors:  David Kim; James Quinn; Benjamin Pinsky; Nigam H Shah; Ian Brown
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

3.  Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.

Authors:  D E Griffith; W M Girard; R J Wallace
Journal:  Am Rev Respir Dis       Date:  1993-05

4.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

5.  Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.

Authors:  Jotam G Pasipanodya; Deborah Ogbonna; Beatriz E Ferro; Gesham Magombedze; Shashikant Srivastava; Devyani Deshpande; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

6.  Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.

Authors:  Marina Tadolini; Luigi Ruffo Codecasa; José-María García-García; François-Xavier Blanc; Sergey Borisov; Jan-Willem Alffenaar; Claire Andréjak; Pierre Bachez; Pierre-Alexandre Bart; Evgeny Belilovski; José Cardoso-Landivar; Rosella Centis; Lia D'Ambrosio; María-Luiza De Souza-Galvão; Angel Dominguez-Castellano; Samir Dourmane; Mathilde Fréchet Jachym; Antoine Froissart; Vania Giacomet; Delia Goletti; Soazic Grard; Gina Gualano; Armine Izadifar; Damien Le Du; Margarita Marín Royo; Jesica Mazza-Stalder; Ilaria Motta; Catherine Wei Min Ong; Fabrizio Palmieri; Frédéric Rivière; Teresa Rodrigo; Denise Rossato Silva; Adrián Sánchez-Montalvá; Matteo Saporiti; Paolo Scarpellini; Frédéric Schlemmer; Antonio Spanevello; Elena Sumarokova; Eva Tabernero; Paul Anantharajah Tambyah; Simon Tiberi; Alessandro Torre; Dina Visca; Miguel Zabaleta Murguiondo; Giovanni Sotgiu; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2020-05-26       Impact factor: 16.671

7.  Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report.

Authors:  Jose A Rodriguez; Heysu Rubio-Gomez; Alejandra A Roa; N Miller; Paula A Eckardt
Journal:  IDCases       Date:  2020-04-20

8.  Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.

Authors:  Qing-Lei Zeng; Zu-Jiang Yu; Jian-Jun Gou; Guang-Ming Li; Shu-Huan Ma; Guo-Fan Zhang; Jiang-Hai Xu; Wan-Bao Lin; Guang-Lin Cui; Min-Min Zhang; Cheng Li; Ze-Shuai Wang; Zhi-Hao Zhang; Zhang-Suo Liu
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

9.  Remdesivir for the Treatment of Covid-19 - Final Report.

Authors:  John H Beigel; Kay M Tomashek; Lori E Dodd; Aneesh K Mehta; Barry S Zingman; Andre C Kalil; Elizabeth Hohmann; Helen Y Chu; Annie Luetkemeyer; Susan Kline; Diego Lopez de Castilla; Robert W Finberg; Kerry Dierberg; Victor Tapson; Lanny Hsieh; Thomas F Patterson; Roger Paredes; Daniel A Sweeney; William R Short; Giota Touloumi; David Chien Lye; Norio Ohmagari; Myoung-Don Oh; Guillermo M Ruiz-Palacios; Thomas Benfield; Gerd Fätkenheuer; Mark G Kortepeter; Robert L Atmar; C Buddy Creech; Jens Lundgren; Abdel G Babiker; Sarah Pett; James D Neaton; Timothy H Burgess; Tyler Bonnett; Michelle Green; Mat Makowski; Anu Osinusi; Seema Nayak; H Clifford Lane
Journal:  N Engl J Med       Date:  2020-10-08       Impact factor: 91.245

10.  Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.

Authors:  Xiaojing Wu; Ying Cai; Xu Huang; Xin Yu; Li Zhao; Fan Wang; Quanguo Li; Sichao Gu; Teng Xu; Yongjun Li; Binghuai Lu; Qingyuan Zhan
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

View more
  6 in total

Review 1.  Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review.

Authors:  Sean Boyd; Saad Nseir; Alejandro Rodriguez; Ignacio Martin-Loeches
Journal:  ERJ Open Res       Date:  2022-07-25

Review 2.  Use of convalescent plasma in COVID-19 patients with immunosuppression.

Authors:  Jonathon W Senefeld; Stephen A Klassen; Shane K Ford; Katherine A Senese; Chad C Wiggins; Bruce C Bostrom; Michael A Thompson; Sarah E Baker; Wayne T Nicholson; Patrick W Johnson; Rickey E Carter; Jeffrey P Henderson; William R Hartman; Liise-Anne Pirofski; R Scott Wright; De Lisa Fairweather; Katelyn A Bruno; Nigel S Paneth; Arturo Casadevall; Michael J Joyner
Journal:  Transfusion       Date:  2021-06-01       Impact factor: 3.337

3.  Comparative survival of environmental and clinical Mycobacterium abscessus isolates in a variety of diverse host cells.

Authors:  Charmie K Vang; Stephanie N Dawrs; Nicole M Oberlag; Anah E Gilmore; Nabeeh A Hasan; Jennifer R Honda
Journal:  J Appl Microbiol       Date:  2022-01-04       Impact factor: 4.059

Review 4.  Clinical Features and Treatment Outcome of Coronavirus and Tuberculosis Co-Infected Patients: A Systematic Review of Case Reports.

Authors:  Hilina Mollalign; Dawit Chala; Dereje Beyene
Journal:  Infect Drug Resist       Date:  2022-07-27       Impact factor: 4.177

5.  Molecular identification of nontuberculous mycobacteria using the rpoB, argH and cya genes analysis.

Authors:  Azar Dokht Khosravi; Mohammad Hashemzadeh; Parisa Rokhfirooz
Journal:  AMB Express       Date:  2022-09-19       Impact factor: 4.126

6.  COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia.

Authors:  Quinto Gesiotto; Asima Cheema; Kishan Avaiya; Bijal Shah; John Greene
Journal:  Cureus       Date:  2021-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.